中国卫生政策研究
中國衛生政策研究
중국위생정책연구
CHINESE JOURNAL OF HEALTH POLICY
2015年
4期
31-34
,共4页
迟垚%吴群红%李斌%高力军%李叶%梁立波%丁玎%宋健%郝模
遲垚%吳群紅%李斌%高力軍%李葉%樑立波%丁玎%宋健%郝模
지요%오군홍%리빈%고력군%리협%량립파%정정%송건%학모
基本药物制度%乡镇卫生院%收入结构
基本藥物製度%鄉鎮衛生院%收入結構
기본약물제도%향진위생원%수입결구
Essential medicine system%Township health centers%Revenue structure
目的:分析基本药物制度对基层医疗机构收入结构的影响。方法:对山西省实施基本药物制度的58家乡镇卫生院的收入状况与结构变化趋势进行分析。结果:随着政府对基层医疗机构投入的增加,基本药物制度基本实现全覆盖,基本药物收入占药品收入比重从2009年的20.45%上升到2013年97.03%,药品收入占总收入的比重下降了18.4%;与此同时,财政补助收入占总收入的比重从2009年的25.77%上升到2013年的54.16%,但业务收入占总收入比重总体呈下降趋势。结论:基本药物制度需要政府财政的大力支持,在进一步完善基层基本药物清单和基层财政补助政策的同时,完善医生薪酬和激励机制并改革不合理的医生劳务定价和补偿机制。
目的:分析基本藥物製度對基層醫療機構收入結構的影響。方法:對山西省實施基本藥物製度的58傢鄉鎮衛生院的收入狀況與結構變化趨勢進行分析。結果:隨著政府對基層醫療機構投入的增加,基本藥物製度基本實現全覆蓋,基本藥物收入佔藥品收入比重從2009年的20.45%上升到2013年97.03%,藥品收入佔總收入的比重下降瞭18.4%;與此同時,財政補助收入佔總收入的比重從2009年的25.77%上升到2013年的54.16%,但業務收入佔總收入比重總體呈下降趨勢。結論:基本藥物製度需要政府財政的大力支持,在進一步完善基層基本藥物清單和基層財政補助政策的同時,完善醫生薪酬和激勵機製併改革不閤理的醫生勞務定價和補償機製。
목적:분석기본약물제도대기층의료궤구수입결구적영향。방법:대산서성실시기본약물제도적58가향진위생원적수입상황여결구변화추세진행분석。결과:수착정부대기층의료궤구투입적증가,기본약물제도기본실현전복개,기본약물수입점약품수입비중종2009년적20.45%상승도2013년97.03%,약품수입점총수입적비중하강료18.4%;여차동시,재정보조수입점총수입적비중종2009년적25.77%상승도2013년적54.16%,단업무수입점총수입비중총체정하강추세。결론:기본약물제도수요정부재정적대력지지,재진일보완선기층기본약물청단화기층재정보조정책적동시,완선의생신수화격려궤제병개혁불합리적의생노무정개화보상궤제。
Objective:To analyze the effects of essential medicine system on revenue structures at primary med-ical institutions. Methods:Data on revenue status and structures from 58 township health centers in Shanxi Province was collected to analyze changes and trends. Results:Along with growing government investments in primary medical institutions, the essential medicine system has fundamentally realized full coverage. The percentage of essential medi-cine revenue to pharmaceutical revenue rose from 20 . 45% in 2009 to 97 . 03% in 2013 , though the percentage of pharmaceutical revenue to total revenue dropped by 18 . 43%. The percentage of fiscal subsidy revenue in total reve-nue rose from 25 . 77% in 2009 to 54 . 16% in 2013 , though the percentage of business revenue to total revenue dropped in general. Conclusions:The essential medicine system requires the government’s financial support. Essen-tial medicine lists and primary financial aid policies should be further improved;doctor reimbursement and incentive mechanisms should be improved as well and unreasonable doctor service pricing and reimbursement mechanisms should be reformed.